Correlation Engine 2.0
Clear Search sequence regions

  • Akt (1)
  • angiogenesis (1)
  • antitumor (4)
  • apoptosis (1)
  • cox- 2 inhibitors (5)
  • drug combinations (1)
  • human (6)
  • macrophage (1)
  • PI3K (1)
  • protein human (1)
  • PTGS2 (1)
  • signal (1)
  • VEGF (1)
  • Sizes of these terms reflect their relevance to your search.

    Chemotherapy with a single chemotherapeutic agent or a combined chemotherapeutic regimen is the clinically standardized treatment for almost all human cancers. Upregulated expression of cyclooxygenase (COX)-2, also known as prostaglandin-endoperoxide synthase (PTGS), is associated with human carcinogenesis and cancer progression and COX-2 inhibitors show antitumor activity in different human cancers. Thus, a combination of chemotherapeutic agents with COX-2 inhibitors has been shown to improve therapeutic effects on human cancers. This review discusses and summarizes recent advances in cancer control and treatment using various antineoplastic drugs combined with COX-2 inhibitors. These combinations showed synergistic antitumor effects. At the gene level, COX-2 inhibitors can reduce inflammatory factors thereby regulating macrophage recruitment for activating the antitumor immune microenvironment; downregulating vascular endothelial growth factor (VEGF) to inhibit tumor angiogenesis; and inhibiting the PI3K/Akt signaling pathway to induce tumor cell apoptosis. In addition, such a combination can reduce toxicity and chemoresistance and enhance radiosensitivity, although COX-2 inhibitors-related cardiotoxicity may potentially affect its use. Further in-depth investigation of these drug combinations is needed to maximize antitumor efficacy and minimize the side effects. Copyright © 2020. Published by Elsevier Masson SAS.


    Shuangshuang Li, Min Jiang, Lu Wang, Shuwen Yu. Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020 Sep;129:110389

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32540642

    View Full Text